Nutramax Laboratories, Inc.

Todd R Henderson

David Griffin

Louis Lippiello

Barbara E Corson

Tarek Hammad

Charles Filburn

Robert W Henderson

Carmelita Frondoza

David Bledsoe

Medhat Soliman

Reinhard Grzanna

Medat Soliman

An orally administrable composition for treating or reducing damage to connective tissue or for treating or reducing inflammatory symptoms associated with damage to connective tissue includes a synergistic combination of: (i) avocado/soybean unsaponifiables; and (ii) lipoic acid, or a salt or derivative thereof. Methods for treating or reducing damage to connective tissue, for treating or reducing inflammatory symptoms associated with damage to connective tissue, or for reducing levels of one or more inflammatory mediators in connective tissue include administering the orally administrable composition to an avian or mammalian subject.

Orally administrable compositions comprising avocado/soybean unsaponifiables and lipoic acid and methods of administration

An anxiolytic composition formulated for oral administration to a mammal includes a synergistic combination of L-theanine, at least one ofand an extract of, and at least one ofand an extract of. The composition may include a combination of an extract ofand a extract of. The synergistic combination may provide an anxiolytic change in a release pattern of one or more brain neurotransmitters, such as glutamate and/or γ-aminobutyric acid (GABA).

Compositions comprising theanine, magnolia, and phellodendron

Compositions are described including a synergistic combination of hydroxytyrosol and 3-O-acetyl-11-keto-β-boswellic acid. The hydroxytyrosol may be sourced from an olive extract and the 3-O-acetyl-11-keto-β-boswellic acid may be sourced from aextract. The compositions may be formulated for oral administration to a mammalian or an avian subject. Methods for treating, repairing, or reducing damage to connective tissue caused by one or more inflammatory mediators and for reducing levels of one or more inflammatory mediators in connective tissue are provided, the methods comprising orally administering the compositions to a subject in need thereof.

Methods for administering compositions comprising hydroxytyrosol and boswellic acid

An anxiolytic composition includes a synergistic combination of one or more of an L-theanine, an s-adenosylmethionine (SAMe), and optionally an extract of, an extract of, and a whey protein.

Compositions comprising theanine, s-adenosylmethionine (SAMe), and/orand

The present application relates to compositions comprising avocado/soybean unsaponifiables ('ASU') and, and related methods of use. In one embodiment, theis aoil extract that is combined with ASU to reduce inflammatory responses and inflammation in humans and animals.

Compositions including cannabis and avocado/soybean unsaponifiables and methods of use

The present invention relates to a composition for the protection, treatment and repair of cartilage in humans and animal joints. The composition contains a combination of unsaponifiable lipids together with one or more of polyphenols and/or catechins. The composition or kit may contain avocado:soybean unsaponifiables (ASU) and green tea.

Combination of unsaponifiable lipids combined with polyphenols and/or catechins for the protection, treatment and repair of cartilage in joints of humans and animals

Compositions are described including a combination of hydroxytyrosol and 3-O-acetyl-11-keto-&#x3b2;-boswellic acid. The hydroxytyrosol may be sourced from an olive extract and the 3-O-acetyl-11-keto-&#x3b2;-boswellic acid may be sourced from aextract. The compositions may be formulated for oral administration to a mammalian or an avian subject. Methods for preventing or reducing an inflammatory response in connective tissue are provided, the methods comprising orally administering the compositions to a subject in need thereof.

Compositions comprising hydroxytyrosol and boswellic acid

An anxiolytic composition includes a synergistic combination of an L-theanine and a whey protein composition.

Compositions comprising theanine and whey protein

Compositions are described including a synergistic combination of hydroxytyrosol and 3-O-acetyl-11-keto-&#x3b2;-boswellic acid. The hydroxytyrosol may be sourced from an olive extract and the 3-O-acetyl-11-keto-&#x3b2;-boswellic acid may be sourced from aextract. The compositions may be formulated for oral administration to a mammalian or an avian subject. Methods for treating, repairing, or reducing damage to connective tissue caused by one or more inflammatory mediators and for reducing levels of one or more inflammatory mediators in connective tissue are provided, the methods comprising orally administering the compositions to a subject in need thereof.

Orally administrable compositions compromising avocado/soybean unsaponifiables and lipoic acid and methods of administration

An anxiolytic composition includes a synergistic combination of one or more of an extract of, an extract of, an L-theanine, a whey protein composition, and/or an s-adenosylmethionine (SAMe).

Compositions comprising magnolia, phellodendron, theanine and/or whey protein

The present invention relates to a composition and a kit for the protection, treatment and repair of cartilage in humans and animal joints. The composition or kit contains a combination of unsaponifiable lipids together with one or more of polyphenols and/or catechins. Preferably, the composition or kit contains avocado:soybean unsaponifiables (ASU) and green tea.

Growing community of inventors

Jarrettsville, MD, United States of America

Todd R Henderson